Scarica l'app Stockscreener
25.79
2.59%
-0.845
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché VKTX Giù?
Forum
Previsione
Precedente Chiudi:
$26.63
Aprire:
$26.4
Volume 24 ore:
509.14K
Relative Volume:
0.08
Capitalizzazione di mercato:
$2.91B
Reddito:
-
Utile/perdita netta:
$-99.15M
Rapporto P/E:
-27.73
EPS:
-0.93
Flusso di cassa netto:
$-74.25M
1 W Prestazione:
-0.38%
1M Prestazione:
+0.35%
6M Prestazione:
-7.29%
1 anno Prestazione:
-58.91%
Intervallo 1D:
$25.56
$26.40
Intervallo di 1 settimana:
$24.52
$27.48
Portata 52W:
$18.92
$81.73
Viking Therapeutics Inc Stock (VKTX) Company Profile
Nome
Viking Therapeutics Inc
Settore
Industria
Telefono
858-704-4660
Indirizzo
9920 PACIFIC HEIGHTS BLVD, SUITE 350, SAN DIEGO, CA
Confronta VKTX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
VKTX
Viking Therapeutics Inc
|
25.85 | 2.81B | 0 | -99.15M | -74.25M | -0.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
383.60 | 97.36B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.95 | 60.19B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.96 | 59.56B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
716.84 | 44.94B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
331.52 | 36.14B | 3.81B | -644.79M | -669.77M | -6.24 |
Viking Therapeutics Inc Stock (VKTX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-29 | Iniziato | Cantor Fitzgerald | Overweight |
| 2025-04-08 | Iniziato | Goldman | Neutral |
| 2025-02-13 | Iniziato | Scotiabank | Sector Outperform |
| 2025-02-07 | Iniziato | Citigroup | Neutral |
| 2024-12-02 | Iniziato | Piper Sandler | Overweight |
| 2024-11-22 | Iniziato | B. Riley Securities | Buy |
| 2024-11-04 | Reiterato | H.C. Wainwright | Buy |
| 2024-09-11 | Iniziato | JP Morgan | Overweight |
| 2024-06-27 | Iniziato | Morgan Stanley | Overweight |
| 2024-05-16 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2024-03-26 | Reiterato | Oppenheimer | Outperform |
| 2024-03-07 | Iniziato | Jefferies | Buy |
| 2024-02-28 | Reiterato | Oppenheimer | Outperform |
| 2023-05-31 | Ripresa | ROTH MKM | Buy |
| 2023-03-28 | Reiterato | Maxim Group | Buy |
| 2023-03-17 | Iniziato | Stifel | Buy |
| 2021-07-29 | Ripresa | BTIG Research | Buy |
| 2021-05-25 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2020-06-05 | Iniziato | BMO Capital Markets | Outperform |
| 2020-05-05 | Iniziato | Chardan Capital Markets | Buy |
| 2020-05-01 | Iniziato | BTIG Research | Buy |
| 2019-07-16 | Iniziato | Oppenheimer | Outperform |
| 2019-06-25 | Iniziato | Stifel | Buy |
| 2019-03-29 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2019-03-14 | Reiterato | Maxim Group | Buy |
| 2019-02-22 | Iniziato | SVB Leerink | Mkt Perform |
| 2018-12-12 | Iniziato | B. Riley FBR | Buy |
| 2018-11-19 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2018-09-18 | Reiterato | H.C. Wainwright | Buy |
| 2018-09-18 | Reiterato | Maxim Group | Buy |
| 2018-09-18 | Reiterato | Raymond James | Outperform |
| 2018-07-20 | Iniziato | SunTrust | Buy |
| 2018-06-28 | Iniziato | Raymond James | Outperform |
| 2018-06-01 | Reiterato | Laidlaw | Buy |
| 2018-05-31 | Reiterato | Maxim Group | Buy |
| 2018-03-26 | Ripresa | H.C. Wainwright | Buy |
| 2017-11-28 | Reiterato | Maxim Group | Buy |
| 2017-11-21 | Iniziato | ROTH Capital | Buy |
Mostra tutto
Viking Therapeutics Inc Borsa (VKTX) Ultime notizie
Can Viking Therapeutics Hold Its Edge as Obesity Rivalry Heats Up? - Zacks Investment Research
Pfizer Is Buying Weight Loss Biotech Metsera. Here's Why Viking Therapeutics Shareholders May Be Cheering. - The Motley Fool
Viking Therapeutics Stock Surges on Promising Obesity Drug Pipeline - AD HOC NEWS
Viking Therapeutics (NASDAQ:VKTX) Trading 6.6% HigherTime to Buy? - MarketBeat
Viking Therapeutics (NASDAQ:VKTX) Trading 7.4% HigherWhat's Next? - MarketBeat
Viking Therapeutics : September 2025 Corporate Presentation - MarketScreener
Are Safety Concerns Around VK2735 Shaping Investor Perceptions of Viking Therapeutics (VKTX)? - simplywall.st
Why Viking Therapeutics Stock Crashed Today - AOL.com
U.S. Capital Wealth Advisors LLC Purchases 27,795 Shares of Viking Therapeutics, Inc. $VKTX - MarketBeat
Viking Therapeutics Shares Dip as Pfizer Chooses Rival Acquisition - AD HOC NEWS
Viking Therapeutics, Inc. (VKTX) Falls More Steeply Than Broader Market: What Investors Need to Know - sharewise.com
Pfizer’s $5B Bet on Metsera ($MTSR) vs Viking Therapeutics ($VKTX) - MSN
Strs Ohio Invests $604,000 in Viking Therapeutics, Inc. $VKTX - MarketBeat
Viking Therapeutics at Bernstein Forum: Strategic Moves in Obesity Market - Investing.com
Transcript : Viking Therapeutics, Inc. Presents at Bernstein 2nd Annual Global Healthcare Conference, Sep-23-2025 11 - MarketScreener
Viking Therapeutics at Bernstein Forum: Strategic Moves in Obesity Market By Investing.com - Investing.com UK
Viking Therapeutics Stock Gets Boost From Pfizer-Metsera Deal, Says BTIG — Retail Slams Rivals For Buying ‘Inferior Pipelines’ - Stocktwits
Exchange Traded Concepts LLC Buys 20,296 Shares of Viking Therapeutics, Inc. $VKTX - MarketBeat
Viking Stock: Oral Study Disappoints, Competitor Gets Bought Out (NASDAQ:VKTX) - Seeking Alpha
Why Viking Therapeutics Shares Are Climbing High - TipRanks
BTIG Reiterates Buy Rating for Viking Therapeutics (VKTX) with $125 Target | VKTX Stock News - GuruFocus
BTIG Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $125 - 富途牛牛
Viking Therapeutics (NASDAQ:VKTX) Earns Buy Rating from BTIG Research - MarketBeat
Viking Therapeutics: Strong Buy Rating Amid Strategic Positioning and Acquisition Potential in the Metabolic Disease Market - TipRanks
Viking Therapeutics (VKTX): Revisiting Valuation After Safety Concerns From Oral Obesity Drug Trial News - simplywall.st
Kingstone Capital Partners Texas LLC Invests $1.37 Million in Viking Therapeutics, Inc. $VKTX - MarketBeat
Viking Therapeutics (NASDAQ:VKTX) Stock Price Up 10.6%Here's Why - MarketBeat
Buy Signal: Can Viking Therapeutics Inc maintain its current growth rateJuly 2025 Intraday Action & Precise Swing Trade Alerts - خودرو بانک
Harbor Capital Advisors Inc. Decreases Holdings in Viking Therapeutics, Inc. $VKTX - MarketBeat
Viking Therapeutics, Inc. $VKTX Shares Acquired by Wesbanco Bank Inc. - MarketBeat
Prediction: Viking Therapeutics Stock Will Double in Value Within the Next 12 Months - AOL.com
Merger Talk: Can Viking Therapeutics Inc expand into new marketsIndex Update & Verified Chart Pattern Signals - khodrobank.com
Rate Hike: What are the future prospects of Viking Therapeutics Inc2025 Biggest Moves & Consistent Income Trade Ideas - khodrobank.com
Aug Setups: Is Asure Software Inc stock forming a cup and handle2025 Trading Volume Trends & Verified Stock Trade Ideas - khodrobank.com
Growth Value: Is Viking Therapeutics Inc stock a value trapJuly 2025 Selloffs & Low Risk Growth Stock Ideas - khodrobank.com
Momentum Shift: Is CPIX exposed to political riskJuly 2025 Trade Ideas & Verified Short-Term Plans - خودرو بانک
Published on: 2025-09-18 21:20:40 - خودرو بانک
Analysts Set Viking Therapeutics, Inc. (NASDAQ:VKTX) Target Price at $87.50 - MarketBeat
Biotech Breakouts: 3 Stocks With Massive Upside Potential - Investing.com
Viking Therapeutics (VKTX) Rebounds on Bargain-Hunting. Are You Missing Out? - MSN
Aug PostEarnings: Will Viking Therapeutics Inc. face regulatory challengesMarket Trend Report & Precise Entry and Exit Recommendations - خودرو بانک
Biotech Breakouts: 3 Stocks With Massive Upside Potential - MarketBeat
Is Viking Therapeutics stock a bargain after this week’s sell-off? - MSN
EV Market: How is Viking Therapeutics Inc managing supply chain issuesJuly 2025 News Drivers & Fast Gain Stock Tips - khodrobank.com
Viking Therapeutics, Inc. $VKTX Position Reduced by Voya Investment Management LLC - MarketBeat
Viking Therapeutics, Inc. $VKTX Shares Acquired by Woodline Partners LP - MarketBeat
Wealth Management Associates Inc. Buys Shares of 9,975 Viking Therapeutics, Inc. $VKTX - MarketBeat
Aug Rallies: Can Viking Therapeutics Inc maintain its current growth rateQuarterly Investment Review & Free Daily Entry Point Trade Alerts - خودرو بانک
Viking Therapeutics, Inc. (VKTX): A Bull Case Theory - MSN
AMGN vs. VKTX: Which Biotech Stock Is the Better Obesity Play? - Yahoo Finance
Viking Therapeutics Inc Azioni (VKTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.28%
0.51%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):